| Tag | Content |
|---|
EnhancerAtlas ID | HS105-05918 |
Organism | Homo sapiens |
Tissue/cell | IMR90 |
Coordinate | chr1:183577060-183577910 |
TF binding sites/motifs | | TF | JASPAR ID | Coordinate | Motif Sequence | Strand | -Log10(p-value) |
| Foxd3 | MA0041.1 | chr1:183577430-183577442 | AAACAAACAAAC | - | 6.32 | | HSF1 | MA0486.2 | chr1:183577701-183577714 | TTCTGGAATTTTC | + | 6.17 | | IRF1 | MA0050.2 | chr1:183577773-183577794 | CATCAGAAAGTGAAAGCATGG | - | 6.1 |
|
| | Number of super-enhancer constituents: 4 | ID | Coordinate | Tissue/cell |
| SE_09925 | chr1:183567023-183580226 | CD14 | | SE_53951 | chr1:183577650-183580049 | Spleen | | SE_59245 | chr1:183570687-183580261 | Ly3 | | SE_65086 | chr1:183576393-183579560 | NHEK |
|
| | Diseases: AD,Huntington,Obesity,Parkinson,Prostate cancer,Schizophrenia and Sleep disorder | | Number of disease enhancers: 1 | Chromosome | Start | End |
|
| | Number: 1 | ID | Chromosome | Start | End |
| GH01I183602 | chr1 | 183571737 | 183579934 |
|
Enhancer Sequence | AAAATCTTAT ATGTAATTCA GGATTATATA GAAGGGCTTG GGTAAAACCT TCAGGGAACA 60
GTGCTAGGCC AAATGAAAAT ACAGTAGTTG GCTGGGCACG GTGGCTCATG CGTGTAATCT 120
TAGCACTTTG GGAGGCTGAG GCAGGTAGAT CACCTGAAGT CAGGAGTTCG AGACCAGCCT 180
GGCCAACATG GTGAAACTCT GTCTCTACTA AAAATACAAA AATTAGCCAG GCTGGTGGTG 240
GGCATCTGTA ATCCCAGCTA CTTGGGAGGC TGAGGCAGGA GAATTGCTTG AGCCTGGGAG 300
GCAGAGGTTG CAGTGAGCTG AGATCAGGCC ACTGCACTCC AGCCTGAGAA ACAGAGTGAG 360
ACTCTTTCTC AAACAAACAA ACAAAAAAAG AAAATACAGT AGTCCCCCCT TATCTGCAGT 420
GGATGCATTC CAAGACCCCC AGTGGATCCC TGAAACCTCA GATAGTACCA AGCCCTATAT 480
ACACTATGTT TTTTGCTGTA TAGTAATGAG TAGGGAGCAT ATACAGTGTG GATACACTGG 540
ACAAAGGGAT GATTCACATC CTAGGCAGGG TAGATCCTGA TTGTATGAGA TTTCATCATG 600
TTACTCAGAA TGATGTGCAT TTAAAACTAT GAATTACTAA TTTCTGGAAT TTTCCATGGA 660
ATATTTTGGG ACTGCAGTTG ACCAGGGGTA ACTGAAACCT CAGGTAAAGG AAACATCAGA 720
AAGTGAAAGC ATGGATAAGG AGGGACTCCT ATAAGCTCTA TGTGGTATGG GCTGGATACC 780
ATTTCCAGAA GATGTCACTG CCTTGTGCTT AATTTCCTAG GACTTTGAAC ACATATATTC 840
AAATGAATTC 850
|
